Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-BRD7 antibody (Catalog #: ARP39018_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BRD7
(Bromodomain Containing 7 (BRD7))
Hintergrund
BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.
Alias Symbols: BP75, CELTIX1, NAG4
Protein Interaction Partner: AGR2,BARD1,BHLHE40,BRD3,BTBD2,DVL1,FTH1,HAP1,HIST1H2AL,HIST2H2BE,HIST2H3A,HIST2H4A,HIST3H3,HNRNPUL1,LAMA4,NEFL,PAFAH1B3,PSMD11,PTPN13,RIF1,RPLP1,SERPINB9,AGR2,BHLHE40,BRCA1,BTBD2,FTH1,HNRNPUL1,IRF2,LAMA4,MYC,PAFAH1B3,POU2F1,PSMD11,RPLP1,SERPINB9